{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
INN:porgaviximab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03374943: Phase 1 Interventional Completed Glioblastoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00770354: Phase 2 Interventional Terminated Breast Carcinoma
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03708224: Phase 2 Interventional Recruiting Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04130854: Phase 2 Interventional Active, not recruiting Locally Advanced Rectal Adenocarcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03941093: Phase 3 Interventional Completed Pancreatic Cancer Non-resectable
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02847949: Phase 1 Interventional Withdrawn NHL
(2021)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN